These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16489638)

  • 1. Cocultivation of umbilical cord blood CD34+ cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells.
    Xie CG; Wang JF; Xiang Y; Qiu LY; Jia BB; Wang LJ; Wang GZ; Huang GP
    World J Gastroenterol; 2006 Jan; 12(3):393-402. PubMed ID: 16489638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD34+ cells in indirect co-culture.
    Xie C; Jia B; Xiang Y; Wang L; Wang G; Huang G; McNiece IK; Wang J
    Cell Tissue Res; 2006 Oct; 326(1):101-10. PubMed ID: 16685532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
    Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells.
    Yamaguchi M; Hirayama F; Kanai M; Sato N; Fukazawa K; Yamashita K; Sawada K; Koike T; Kuwabara M; Ikeda H; Ikebuchi K
    Exp Hematol; 2001 Feb; 29(2):174-82. PubMed ID: 11166456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells.
    Kadekar D; Kale V; Limaye L
    Stem Cell Res Ther; 2015 Oct; 6():201. PubMed ID: 26481144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system.
    Kawada H; Ando K; Tsuji T; Shimakura Y; Nakamura Y; Chargui J; Hagihara M; Itagaki H; Shimizu T; Inokuchi S; Kato S; Hotta T
    Exp Hematol; 1999 May; 27(5):904-15. PubMed ID: 10340407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum.
    Yamaguchi M; Hirayama F; Murahashi H; Azuma H; Sato N; Miyazaki H; Fukazawa K; Sawada K; Koike T; Kuwabara M; Ikeda H; Ikebuchi K
    Cytotherapy; 2002; 4(2):109-18. PubMed ID: 12006206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells.
    Gan OI; Murdoch B; Larochelle A; Dick JE
    Blood; 1997 Jul; 90(2):641-50. PubMed ID: 9226164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells.
    Su RJ; Zhang XB; Li K; Yang M; Li CK; Fok TF; James AE; Pong H; Yuen PM
    Br J Haematol; 2002 Jun; 117(3):735-46. PubMed ID: 12028051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
    Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
    Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
    Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
    Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified in vitro conditions for cord blood-derived long-term culture-initiating cells.
    Podestà M; Piaggio G; Pitto A; Zocchi E; Soracco M; Frassoni F; Luchetti S; Painelli E; Bacigalupo A
    Exp Hematol; 2001 Mar; 29(3):309-14. PubMed ID: 11274758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.